Systemic anti-CD20 (rituximab) as primary treatment for symptomatic primary uveal lymphoma

PURPOSE: Uveal lymphomas are indolent, frequently choroid-involving neoplasms that are mainly CD20-positive B-cell extranodal marginal zone lymphoma. Irreversible visual loss may occur from retinal detachment and/or glaucoma among untreated symptomatic patients, or from radiation-induced changes sec...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Am J Ophthalmol Case Rep
Autori principali: Tiu Teo, Honeylen Maryl, Çiftçi, Süleyman, Elner, Victor Maurice, Demirci, Hakan
Natura: Artigo
Lingua:Inglês
Pubblicazione: Elsevier 2019
Soggetti:
Case Report
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6586989/
https://ncbi.nlm.nih.gov/pubmed/31249903
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ajoc.2019.100484
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi